Black Diamond Financial’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-71,000
| Closed | -$415K | – | 120 |
|
|
2022
Q4 | $415K | Hold |
71,000
| – | – | 0.15% | 67 |
|
|
2022
Q3 | $476K | Buy |
71,000
+2,000
| +3% | +$13.4K | 0.19% | 62 |
|
|
2022
Q2 | $290K | Buy |
69,000
+23,000
| +50% | +$96.7K | 0.11% | 86 |
|
|
2022
Q1 | $155K | Hold |
46,000
| – | – | 0.05% | 122 |
|
|
2021
Q4 | $145K | Hold |
46,000
| – | – | 0.05% | 93 |
|
|
2021
Q3 | $150K | Buy |
46,000
+11,500
| +33% | +$37.5K | 0.07% | 75 |
|
|
2021
Q2 | $146K | Buy |
+34,500
| New | +$146K | 0.06% | 84 |
|